Jayne Hrdlicka whacks A2 Mgt, page-96

"After making 2020 a year of both delivery and progress under serious challenging conditions, we know Q1 2021 is going to be heading tough comparables in particular in our SN Chinese operations and that governmental health strategies around the world will continue to create uncertainties on the speed of recovery of mobility in indexes that will weigh a bit longer on our water business performance.

2021 is therefore going to be a year of recovery. we are focused on preparing our return to sales growth as soon as Q2, and are fully confident that we are building the right conditions and momentum to reconnect with our profitable growth agenda as soon as H2.

In this context, we fully recognize that our share price is not where we would like it to be and we are pleased that this FY announcement resumes our ability to dialogue openly with our shareholders, in preparation of our important CME On March 25, when we will share more on the growth platforms underlying our categories and countries, as well as our progress on our transformation plans, which will provide the necessary support to our full ability to unlock our short and mid term profitable growth opportunities.” https://www.danone.com/investor-relations/results-center.html


Agree with some others posters and this is kind of communication I'd like to see from a2 executives at this stage. The above is an example of how Danone communicate with their shareholders and the market. So, a2 BOD and CEO can learn a thing or two from competitors.
On another topic (I think someone already pointed that out), the current issues that a2 is dealing with are not company specific. They struck whole industry worldwide. Danone had to go through exactly the same problems:

"Infant formula sales in China from cross-border channels continued to contract sharply (-45%) given the ongoing Hong-Kong border closure and travel limitations with mainland China, but showed a sequential improvement compared to the previous quarter.
On the other hand, domestic sales of infant formula in China were back to growth in the quarter, at low-single-digit rate. The eCommerce channel continued to grow significantly, at approximately +45% in the quarter, with all categories contributing to growth."
"Specialized Nutrition posted net sales growth of -0.9% in 2020 on a like-for-like basis and recurring operating margin decreased by -74bps to 24.5%, notably reflecting the negative country mix from Infant Nutrition in China, as well as Covid-related costs incurred this year."
"While cross-border channels sequentially improved from last quarter, they were still severely penalized by ongoing Hong-Kong border closure and travel limitations with mainland China, declining by -45% in the fourth quarter compared to last year. On the other hand, domestic channels were back to growth in the quarter, driven by the performance of Aptamil that gained market shares"

So, if Danone have exactly the same issues and see good recovery prospects by the end of the year I think we can expect the same from a2. I just wish they have communicated better with shareholders.